
This is important work that all ID/CMs should be aware of.
Francesco Cogliati Dezza@Fra_CogliatiD92
@ESCMID day 2! 💥Temocillin not inferior to meropenem 📢New alternative for ESBL+ is coming? 🦠Presented data on RCT ASTARTÉ at #ESCMIDGlobal working on final analysis @jesusrbano @syctong @HUVMacarena @SaludISCIII
English

















